Virax Biolabs Group Limited VRAX
0.79 USD -0.39 (-32.89%)
At closeNov 6, 2026, 7:41 PM EST
0.75 -0.04 -5.29%
After hours · Nov 6, 7:41 PM ET
0.63 Day range 0.9899
0.7919 52-week range 17.20
- YTD
- -90.85%
- 1 year
- -93.66%
Revenue & Expenses
Latest period ending Mar 31, 2026 · select a line to chart its full history
Income statement
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 12.42K | 6.33K | 156.42K | 8.56K | 0 | |
| 7.69K | -53.07K | 50.59K | -1.36K | 0 | |
| -6.40M | -6.08M | -6.53M | -5.73M | -1.73M | |
| -5.02M | -6.06M | -6.73M | -5.46M | -1.71M | |
| -12.64 | -40.62 | -83.90 | -128.00 | -44.80 |
Balance sheet
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 6.44M | 4.23M | 3.59M | 9.35M | 21.76K | |
| 8.32M | 6.43M | 5.48M | 9.81M | 48.71K | |
| 989.83K | 964.75K | 345.19K | 908.40K | 1.25M | |
| 414.39K | 377.00K | 224.30K | 146.25K | 0 | |
| 7.58M | 5.70M | 5.37M | 9.13M | -974.58K |
Cash flow
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| -4.62M | -4.56M | -6.40M | -4.18M | -809.07K | |
| -255.83K | -603.89K | -1.16M | -178.40K | 0 | |
| 7.09M | 5.81M | 1.80M | 13.69M | 813.21K | |
| -255.83K | -603.89K | -1.16M | -178.40K | 0 | |
| 2.21M | 639.70K | -5.76M | 9.33M | 4.13K |